E-monitoring to increase treatment quality and functional capacity in young rheumatoid arthritis patients with high disease activity

E-monitoring to increase treatment quality and functional capacity in young rheumatoid arthritis patients with high disease activity - Rhe-Turn

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00034589

Enrollment

185

Registered

2024-07-04

Start date

2024-08-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M08.8 M08.3 M08.4 M08.8

Interventions

Group 1: Intervention a: Guideline therapy and individualized sports promotion RSK-Rhe-Turn (incl. RSK sports recommendation) with unrestricted access to the app: feedback query depending on disease a

Eligibility

Sex/Gender

All

Age

10 Years to 20 Years

Inclusion criteria

Inclusion criteria: Diagnosis of JIA according to ILAR criteria active JIA disease at least moderate disease activity according to cJADAS10 (clinical Juvenile Arthritis Disease Activity Score for 10 joints;>1.5 for oligoarthritis; >2.5 for polyarthritis) PWC test feasible German-speaking written consent for study participation (patient and parent/guardian) access to digital devices (smartphone, tablet)

Exclusion criteria

Exclusion criteria: Non-infectious fever lasting more than 5 days and/or systemic JIA Neurological, cardiac, orthopaedic, metabolic or pulmonary disease limiting physical activity Pregnancy / breastfeeding Chronic pain disorder Simultaneous participation in behavioral or exercise therapy intervention studies Simultaneous participation in a pharmaceutical intervention study Due to language or mental barriers, patients and/or their relatives are unable to understand the study content and the information provided

Design outcomes

Primary

Measure	Time frame
The primary endpoint of the study is the change in endurance capacity (Physical Working Capacity (PWC) 170 test). The parameters are recorded at the measurement points in the clinic (t0, t1).	—

Secondary

Measure	Time frame
Secondary endpoints are the tolerability and safety (inflammatory activity, pain) of the intervention and the health-related quality of life. The parameters are collected at the measurement points in the clinic (t0, t1) and at home in the period in between (t0-t1) and some are also collected afterwards (t2). For this purpose, clinical parameters and subjective parameters are used in a patient survey.	—

Measure

Time frame

Secondary endpoints are the tolerability and safety (inflammatory activity, pain) of the intervention and the health-related quality of life. The parameters are collected at the measurement points in the clinic (t0, t1) and at home in the period in between (t0-t1) and some are also collected afterwards (t2). For this purpose, clinical parameters and subjective parameters are used in a patient survey.

—

Countries

Germany

Contacts

Public ContactJosephine Gizik

Technische Universität München, TUM School of Medicine and Health, Department Sport and Health Sciences, Professur für Biomechanik im Sport

josephine.gizik@tum.de+49 89 289 24648

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026